Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
207.8 USD | -0.10% | -4.01% | -10.37% |
04:55pm | UBS Adjusts Price Target on Madrigal Pharmaceuticals to $411 From $410, Maintains Buy Rating | MT |
05-07 | Sector Update: Health Care Stocks Steady Pre-Bell Tuesday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.37% | 4.43B | |
+2.46% | 108B | |
+9.64% | 105B | |
+1.57% | 23.46B | |
-11.82% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.76% | 17.19B | |
+5.92% | 13.99B | |
+35.12% | 12.53B |
- Stock Market
- Equities
- MDGL Stock
- News Madrigal Pharmaceuticals, Inc.
- H.C. Wainwright Adjusts Price Target on Madrigal Pharmaceuticals to $425 From $405, Maintains Buy Rating